CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,509 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00000785
NCT00000785N/ACompleted

A Registry of Tuberculosis Cases in the CPCRA

National Institute of Allergy and Infectious Diseases (NIAID)·observational·Posted Aug 31, 2001·Updated Oct 1, 2013

In Brief

An observational study for HIV Infections and Tuberculosis. Completed, enrolled 1,509 participants across 13 sites.

Detailed Summary

PRIMARY: To estimate the proportion of tuberculosis patients in the CPCRA who have drug-resistant tuberculosis (TB) and to describe the patterns of drug resistance. SECONDARY: To compare drug resistance data on the Mycobacterium tuberculosis isolates of HIV-infected patients to those of HIV-uninfected patients who are being followed in the CPCRA. To assess the relationship of resistance data with geographic, demographic, and HIV and TB risk factor information. Geographic areas and demographic subgroups affected by the TB epidemic appear to be congruent and associated with the concurrent HIV epidemic. The total number of CPCRA patients who will develop, or who have experienced, confirmed TB is unknown. It is critical to determine the depth and breadth of the current problem of drug-resistant TB.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedAug 31, 2001
Enrollment StartAug 1, 1992
Primary CompletionJun 1, 1994
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 24.8 years ago